Research Progress in Mechanism of Anticancer Action of Shikonin Targeting Reactive Oxygen Species

Explore the intricate role of reactive oxygen species (ROS) in cancer development and how shikonin and its derivatives can strategically target these molecules to induce cancer cell death, modulate signaling pathways, and enhance chemotherapy responsiveness, offering novel insights for anti-cancer therapy research and design.